Hyderabad Doctor Sivaranjani Santosh Cuts Rare Disease Medicine Cost from Rs 9 Crore to Rs 2.5 Lakh for Seven Children
A dedicated children's doctor in Hyderabad has brought new hope to families fighting a rare and painful genetic illness. Dr Sivaranjani Santosh worked closely with international health groups to lower the yearly cost of a vital medicine from an impossible Rs 9 crore down to just Rs 2.5 lakh per child. Because of her tireless effort and the kindness of public donors, seven young children across India will receive a full year of this life-saving treatment without paying a single rupee.
The inspiring journey started with a little boy named Arav, who was under the medical care of Dr Sivaranjani. Arav was diagnosed with a rare genetic health problem that stops his body and brain from growing properly. His mother, Pavitra, was trying her best to keep him healthy by ordering a special medicine from Germany. However, the monthly bill for importing that medicine came to roughly Rs 12 lakh to Rs 13 lakh. Paying such a massive amount every single month was impossible for a normal family, leaving the mother deeply worried about her son's future.
Seeing the mother's struggle, Dr Sivaranjani decided she could not stay silent. She first tried to get the medicine at a lower price through a special kindness program run by the European drug maker Egetis Therapeutics, but that attempt did not work out. Refusing to give up, the doctor turned to the public for help. On September 7, she shared a heartfelt message on social media explaining how a life-saving medicine was priced completely out of reach for ordinary parents.
Her honest post quickly spread online and caught the attention of kind people and health experts around the world. Soon, K M Gopakumar from Access to Medicines India joined hands with her to find a practical solution. Together, they reached out to a group in the Netherlands called the Pharmaceutical Accountability Foundation. This global foundation works hard to make sure expensive medicines are made fair and affordable for people who truly need them.
The Dutch foundation partnered with Transvaal Pharmacy, a trusted medicine maker located in The Hague. Instead of buying the costly brand-name pills sold by big drug companies, the skilled pharmacists used the main raw ingredient of the drug to make custom batches in their own lab. In medical terms, this safe method of making custom-sized batches of medicine for specific patients is known as pharmaceutical compounding. Because it avoids heavy brand markups, the final price dropped dramatically.
The medicine at the center of this story is called Tiratricol. Doctors use it to treat a rare condition known as Allan Herndon Dudley syndrome, often called AHDS. This illness happens due to a small fault in a specific gene inside the body. Normally, this gene helps carry important thyroid hormones directly into the brain cells. When the gene does not work right, the brain does not get the fuel it needs to grow.
Without proper treatment, children born with AHDS face severe health challenges from a very young age. They often suffer from extreme muscle weakness, trouble holding up their heads, difficulty speaking, and slow physical and mental growth. Because the thyroid hormones build up in the blood instead of entering the brain, the child's body also faces other health troubles. While Tiratricol does not completely cure the genetic fault, taking it daily helps control the hormone levels and protects the child from further harm.
Branded versions of Tiratricol sold in foreign markets cost anywhere between Rs 4.68 crore and Rs 9 crore for just one child for a single year. Since patients need to take these tablets or capsules for their entire lives, almost no family in India can afford the commercial price. By getting the custom-made version from the Netherlands, the yearly cost dropped to around Rs 2.5 lakh per child. This massive price drop turned an impossible dream into a real medical rescue.
Once the low-cost supply was arranged, the team looked for other children in India suffering from the exact same rare illness. Alongside two young patients under Dr Sivaranjani's care in Hyderabad, doctors found five more children at the Christian Medical College in Vellore. The total cost to supply the medicine for all seven children for one year came to roughly Rs 15.09 lakh. To make sure the parents felt zero financial burden, Dr Sivaranjani raised Rs 6.09 lakh from generous donors in India, while the Dutch foundation raised the remaining amount of about Rs 9.13 lakh in the Netherlands.
Government health officials also stepped in to help by granting special import permits so the custom medicine could enter India legally for these seven patients. Because the custom-made medicine stays fresh for six months, it is being brought into the country in two separate batches. The first batch of medicines is scheduled to be handed over to the families on November 30, with two children receiving their supply in Hyderabad and five children getting theirs in Bengaluru.
While celebrating this huge victory, Dr Sivaranjani pointed out that bringing medicines from foreign countries every few months is only a temporary fix. She strongly believes that Indian labs have all the skills and tools needed to make this exact medicine right here at home. Making it locally would lower the price even further and remove the stress of international shipping and import paperwork.
Looking ahead, the Hyderabad doctor plans to write to the central government to push for local production of rare disease medicines. She is also working with other medical experts to run a special nationwide search to find more children living with AHDS who might not even know a treatment exists. Dr Sivaranjani, who is already well known across the country for fighting against fake health drinks and protecting child health, has once again proved that one determined voice can save young lives and challenge unfair drug prices.
